Up-regulation of corticotropin releasing hormone is associated with the downregulation of corticotropinreleasing hormone binding protein and up-regulation of IL33 and IL-8 expression in psoriasis
Purpose: To determine the expression of corticotropin-releasing hormone (CRH) in psoriasis and normal skin biopsy samples, and to correlate the expression of CRH with the expression of CRHBP and inflammatory cytokines IL-8 and IL-33.
Methods: Psoriasis and normal skin biopsy samples were obtained from three psoriatic and three normal healthy patients. The mRNA expression was examined by quantitative real-time polymerase chain reaction (qRT-PCR). Protein expression analysis was carried out by western blotting and then further validated by immunohistochemistry.
Results: The results revealed that the expression of CRH was highly significantly (p < 0.0001) in psoriatic skin samples compared to normal skin samples. The increase of CRH in psoriatic samples ranged from 2.7- to 3.5-fold. Expression of CRH was associated with concomitant downregulation of CRHBP in all the psoriatic skin biopsy samples. Expression of CRHBP was 3- to 6.2-fold lower in psoriatic samples compared to normal skin samples. Analysis of mRNA expression of IL-8 and IL-33, revealed that expression of both IL-8 and IL-33 was significantly (p < 0.0001) upregulated in psoriatic skin samples. Expression of IL-8 and IL-33 was approximately 4.1 and 3.2-fold higher in psoriatic skin samples than in normal skin samples. Expression of CRHBP, IL-8 and IL-33 was further confirmed by western blotting and immunohistochemistry which the findings from quantitative RT-PCR.
Conclusion: Taken together, the results confirm that the expression of CRH is associated with suppression of CRHBP and upregulation of IL-8 and IL-33.
Keywords: Psoriasis, Corticotropin releasing hormone, Inflammatory cytokines, Interleukin, Skin biopsy
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.